5.1. Analysis.
Comparison 5 Subcutaneous omalizumab + steroid versus placebo + steroid (trial extension), Outcome 1 Number of participants achieving complete inhaled steroid withdrawal.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.